179 related articles for article (PubMed ID: 21941087)
1. FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy.
Pandit B; Gartel AL
Cell Cycle; 2011 Oct; 10(19):3269-73. PubMed ID: 21941087
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma.
Uddin S; Hussain AR; Ahmed M; Siddiqui K; Al-Dayel F; Bavi P; Al-Kuraya KS
Haematologica; 2012 Jul; 97(7):1092-100. PubMed ID: 22271891
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibitors suppress expression of NPM and ARF proteins.
Pandit B; Gartel AL
Cell Cycle; 2011 Nov; 10(22):3827-9. PubMed ID: 22071628
[TBL] [Abstract][Full Text] [Related]
4. Combination of oxidative stress and FOXM1 inhibitors induces apoptosis in cancer cells and inhibits xenograft tumor growth.
Halasi M; Pandit B; Wang M; Nogueira V; Hay N; Gartel AL
Am J Pathol; 2013 Jul; 183(1):257-65. PubMed ID: 23665201
[TBL] [Abstract][Full Text] [Related]
5. FoxM1 is a general target for proteasome inhibitors.
Bhat UG; Halasi M; Gartel AL
PLoS One; 2009 Aug; 4(8):e6593. PubMed ID: 19672316
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells.
Jiang L; Wang P; Chen L; Chen H
Int J Clin Exp Pathol; 2014; 7(9):5450-60. PubMed ID: 25337187
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells.
Zhu K; Dunner K; McConkey DJ
Oncogene; 2010 Jan; 29(3):451-62. PubMed ID: 19881538
[TBL] [Abstract][Full Text] [Related]
8. Suppression of FOXM1 sensitizes human cancer cells to cell death induced by DNA-damage.
Halasi M; Gartel AL
PLoS One; 2012; 7(2):e31761. PubMed ID: 22393369
[TBL] [Abstract][Full Text] [Related]
9. A new target for proteasome inhibitors: FoxM1.
Gartel AL
Expert Opin Investig Drugs; 2010 Feb; 19(2):235-42. PubMed ID: 20074015
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosis.
Saulle E; Petronelli A; Pasquini L; Petrucci E; Mariani G; Biffoni M; Ferretti G; Scambia G; Benedetti-Panici P; Cognetti F; Humphreys R; Peschle C; Testa U
Apoptosis; 2007 Apr; 12(4):635-55. PubMed ID: 17252198
[TBL] [Abstract][Full Text] [Related]
11. The Isopeptidase Inhibitor G5 Triggers a Caspase-independent Necrotic Death in Cells Resistant to Apoptosis: A COMPARATIVE STUDY WITH THE PROTEASOME INHIBITOR BORTEZOMIB.
Fontanini A; Foti C; Potu H; Crivellato E; Maestro R; Bernardi P; Demarchi F; Brancolini C
J Biol Chem; 2009 Mar; 284(13):8369-81. PubMed ID: 19139105
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma.
Hui B; Shi YH; Ding ZB; Zhou J; Gu CY; Peng YF; Yang H; Liu WR; Shi GM; Fan J
Cancer; 2012 Nov; 118(22):5560-71. PubMed ID: 22517429
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of FOXM1 by thiostrepton sensitizes medulloblastoma to the effects of chemotherapy.
Lin J; Zheng Y; Chen K; Huang Z; Wu X; Zhang N
Oncol Rep; 2013 Oct; 30(4):1739-44. PubMed ID: 23912794
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of autophagy enhances apoptosis induced by proteasome inhibitor bortezomib in human glioblastoma U87 and U251 cells.
Zhang X; Li W; Wang C; Leng X; Lian S; Feng J; Li J; Wang H
Mol Cell Biochem; 2014 Jan; 385(1-2):265-75. PubMed ID: 24104452
[TBL] [Abstract][Full Text] [Related]
15. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H
J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic transformation confers a selective susceptibility to the combined suppression of the proteasome and autophagy.
Ding WX; Ni HM; Gao W; Chen X; Kang JH; Stolz DB; Liu J; Yin XM
Mol Cancer Ther; 2009 Jul; 8(7):2036-45. PubMed ID: 19584239
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosis.
Bazzaro M; Lee MK; Zoso A; Stirling WL; Santillan A; Shih IeM; Roden RB
Cancer Res; 2006 Apr; 66(7):3754-63. PubMed ID: 16585202
[TBL] [Abstract][Full Text] [Related]
18. New potential anti-cancer agents synergize with bortezomib and ABT-737 against prostate cancer.
Pandit B; Gartel AL
Prostate; 2010 Jun; 70(8):825-33. PubMed ID: 20058240
[TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells.
Yang W; Monroe J; Zhang Y; George D; Bremer E; Li H
Cancer Lett; 2006 Nov; 243(2):217-27. PubMed ID: 16413676
[TBL] [Abstract][Full Text] [Related]
20. Antioxidants block proteasome inhibitor function in endometrial carcinoma cells.
Llobet D; Eritja N; Encinas M; Sorolla A; Yeramian A; Schoenenberger JA; Llombart-Cussac A; Marti RM; Matias-Guiu X; Dolcet X
Anticancer Drugs; 2008 Feb; 19(2):115-24. PubMed ID: 18176107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
